On 31 December 2018, Biotage AB (STO:BIOT) released its earnings update. Generally, it seems that analyst expectations are fairly bearish, with earnings expected to grow by 16% in the upcoming year ...
With the expansion of remote patient monitoring, the demand for infrastructure to support connected medical devices has soared. The challenge is to get equipped with the right skill sets to build a ...
Biotage AB (OM:BIOT) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the case of BIOT, it is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results